105 related articles for article (PubMed ID: 38609948)
21. Lipid accumulation induced by APOE4 impairs microglial surveillance of neuronal-network activity.
Victor MB; Leary N; Luna X; Meharena HS; Scannail AN; Bozzelli PL; Samaan G; Murdock MH; von Maydell D; Effenberger AH; Cerit O; Wen HL; Liu L; Welch G; Bonner M; Tsai LH
Cell Stem Cell; 2022 Aug; 29(8):1197-1212.e8. PubMed ID: 35931030
[TBL] [Abstract][Full Text] [Related]
22. A Comprehensive Guide for Assessing Covalent Inhibition in Enzymatic Assays Illustrated with Kinetic Simulations.
Mons E; Roet S; Kim RQ; Mulder MPC
Curr Protoc; 2022 Jun; 2(6):e419. PubMed ID: 35671150
[TBL] [Abstract][Full Text] [Related]
23. DeePred-BBB: A Blood Brain Barrier Permeability Prediction Model With Improved Accuracy.
Kumar R; Sharma A; Alexiou A; Bilgrami AL; Kamal MA; Ashraf GM
Front Neurosci; 2022; 16():858126. PubMed ID: 35592264
[TBL] [Abstract][Full Text] [Related]
24. lncRNA PRADX is a Mesenchymal Glioblastoma Biomarker for Cellular Metabolism Targeted Therapy.
Xu C; Zhao J; Song J; Xiao M; Cui X; Xin L; Xu J; Zhang Y; Yi K; Hong B; Tong F; Tian S; Tan Y; Kang C; Fang C
Front Oncol; 2022; 12():888922. PubMed ID: 35574370
[TBL] [Abstract][Full Text] [Related]
25. Loss of REST in breast cancer promotes tumor progression through estrogen sensitization, MMP24 and CEMIP overexpression.
Cloud AS; Vargheese AM; Gunewardena S; Shimak RM; Ganeshkumar S; Kumaraswamy E; Jensen RA; Chennathukuzhi VM
BMC Cancer; 2022 Feb; 22(1):180. PubMed ID: 35177031
[TBL] [Abstract][Full Text] [Related]
26. Dysregulated lipid metabolism blunts the sensitivity of cancer cells to EZH2 inhibitor.
Zhang T; Guo Z; Huo X; Gong Y; Li C; Huang J; Wang Y; Feng H; Ma X; Jiang C; Yin Q; Xue L
EBioMedicine; 2022 Mar; 77():103872. PubMed ID: 35158113
[TBL] [Abstract][Full Text] [Related]
27. Cancer cell heterogeneity and plasticity: A paradigm shift in glioblastoma.
Yabo YA; Niclou SP; Golebiewska A
Neuro Oncol; 2022 May; 24(5):669-682. PubMed ID: 34932099
[TBL] [Abstract][Full Text] [Related]
28. Targeted Covalent Inhibition of Small CTD Phosphatase 1 to Promote the Degradation of the REST Transcription Factor in Human Cells.
Medellin B; Yang W; Konduri S; Dong J; Irani S; Wu H; Matthews WL; Zhang ZY; Siegel D; Zhang Y
J Med Chem; 2022 Jan; 65(1):507-519. PubMed ID: 34931516
[TBL] [Abstract][Full Text] [Related]
29. Comprehensive Analysis of REST/NRSF Gene in Glioma and Its ceRNA Network Identification.
Zhang Y; Wang Q; Wang Z; Zhang C; Xu X; Xu J; Ren H; Shao X; Zhen X; Zhang L; Yu Y
Front Med (Lausanne); 2021; 8():739624. PubMed ID: 34859007
[TBL] [Abstract][Full Text] [Related]
30. Mechanism of REST/NRSF regulation of clustered protocadherin α genes.
Tang Y; Jia Z; Xu H; Da LT; Wu Q
Nucleic Acids Res; 2021 May; 49(8):4506-4521. PubMed ID: 33849071
[TBL] [Abstract][Full Text] [Related]
31. Leveraging Single-Cell Approaches in Cancer Precision Medicine.
Nath A; Bild AH
Trends Cancer; 2021 Apr; 7(4):359-372. PubMed ID: 33563578
[TBL] [Abstract][Full Text] [Related]
32. Mitochondrial dysfunction and apoptosis underlie the hepatotoxicity of perhexiline.
Ren Z; Chen S; Seo JE; Guo X; Li D; Ning B; Guo L
Toxicol In Vitro; 2020 Dec; 69():104987. PubMed ID: 32861758
[TBL] [Abstract][Full Text] [Related]
33. An image J plugin for the high throughput image analysis of in vitro scratch wound healing assays.
Suarez-Arnedo A; Torres Figueroa F; Clavijo C; Arbeláez P; Cruz JC; Muñoz-Camargo C
PLoS One; 2020; 15(7):e0232565. PubMed ID: 32722676
[TBL] [Abstract][Full Text] [Related]
34. Longer-term (≥ 2 years) survival in patients with glioblastoma in population-based studies pre- and post-2005: a systematic review and meta-analysis.
Poon MTC; Sudlow CLM; Figueroa JD; Brennan PM
Sci Rep; 2020 Jul; 10(1):11622. PubMed ID: 32669604
[TBL] [Abstract][Full Text] [Related]
35. Neuronal Repressor REST Controls Ewing Sarcoma Growth and Metastasis by Affecting Vascular Pericyte Coverage and Vessel Perfusion.
Zhou Z; Yang Y; Wang F; Kleinerman ES
Cancers (Basel); 2020 May; 12(6):. PubMed ID: 32486064
[TBL] [Abstract][Full Text] [Related]
36. Understanding Glioblastoma Biomarkers: Knocking a Mountain with a Hammer.
Hassn Mesrati M; Behrooz AB; Y Abuhamad A; Syahir A
Cells; 2020 May; 9(5):. PubMed ID: 32429463
[TBL] [Abstract][Full Text] [Related]
37. Kinetic Optimization of Lysine-Targeting Covalent Inhibitors of HSP72.
Pettinger J; Carter M; Jones K; Cheeseman MD
J Med Chem; 2019 Dec; 62(24):11383-11398. PubMed ID: 31725295
[TBL] [Abstract][Full Text] [Related]
38. Metabolic Abnormalities in Glioblastoma and Metabolic Strategies to Overcome Treatment Resistance.
Zhou W; Wahl DR
Cancers (Basel); 2019 Aug; 11(9):. PubMed ID: 31450721
[TBL] [Abstract][Full Text] [Related]
39. A dominant-negative effect drives selection of
Boettcher S; Miller PG; Sharma R; McConkey M; Leventhal M; Krivtsov AV; Giacomelli AO; Wong W; Kim J; Chao S; Kurppa KJ; Yang X; Milenkowic K; Piccioni F; Root DE; Rücker FG; Flamand Y; Neuberg D; Lindsley RC; Jänne PA; Hahn WC; Jacks T; Döhner H; Armstrong SA; Ebert BL
Science; 2019 Aug; 365(6453):599-604. PubMed ID: 31395785
[No Abstract] [Full Text] [Related]
40. Targeting Long Chain Acyl-CoA Synthetases for Cancer Therapy.
Rossi Sebastiano M; Konstantinidou G
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31344914
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
